| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Elevation Oncology, Inc. | CHIEF FINANCIAL OFFICER | Restricted Stock Unit | 2,100 | $1,612 | $0.6717 | 15 May 2025 | Direct |
| Elevation Oncology, Inc. | CHIEF FINANCIAL OFFICER | Common Stock | 0 | $0 | $0.3600 | 23 Jul 2025 | Direct |
| Elevation Oncology, Inc. | CHIEF FINANCIAL OFFICER | Stock Option (Right to Buy) | 0 | 23 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ELEV | Elevation Oncology, Inc. | 23 Jul 2025 | 9 | -$13,665 | 4 | CHIEF FINANCIAL OFFICER | 24 Jul 2025, 16:10 |
| ELEV | Elevation Oncology, Inc. | 15 May 2025 | 4 | -$235 | 4 | CHIEF FINANCIAL OFFICER | 19 May 2025, 16:15 |
| ELEV | Elevation Oncology, Inc. | 15 Feb 2025 | 7 | -$1,927 | 4 | CHIEF FINANCIAL OFFICER | 19 Feb 2025, 16:20 |
| ELEV | Elevation Oncology, Inc. | 15 Nov 2024 | 3 | -$52.09 | 4 | CHIEF FINANCIAL OFFICER | 19 Nov 2024, 16:15 |
| ELEV | Elevation Oncology, Inc. | 15 Aug 2024 | 3 | -$64.26 | 4 | CHIEF FINANCIAL OFFICER | 19 Aug 2024, 16:15 |
| ELEV | Elevation Oncology, Inc. | 15 May 2024 | 3 | -$373 | 4 | CHIEF FINANCIAL OFFICER | 17 May 2024, 16:10 |
| ELEV | Elevation Oncology, Inc. | 15 Feb 2024 | 5 | -$1,116 | 4 | CHIEF FINANCIAL OFFICER | 20 Feb 2024, 16:57 |
| ELEV | Elevation Oncology, Inc. | 12 Jul 2023 | 1 | $0 | 4 | CHIEF FINANCIAL OFFICER | 14 Jul 2023, 16:29 |
| ELEV | Elevation Oncology, Inc. | 12 Jul 2023 | 0 | $0 | 3 | CHIEF FINANCIAL OFFICER | 14 Jul 2023, 16:26 |